Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery Lecanemab: “The Benefit is Real; So Too are the Risks.” That’s from coverage in The New York Times, which uses a sober, non-hyped headline of “Alzheimer’s Drug May Benefit Some Patients, New Data Shows.” We all hope this proves ...
Drug Discovery Industry Roundup with Barry Bunin — December 2022 Drug Discovery Industry Roundup with Barry Bunin — December 2022 Barry Bunin, PhD Founder & CEO Collaborative Drug Discovery Lecanemab: “The Benefit is Real; So Too are the Risks.” That’s from coverage in The New York Times, which uses a sober, non-hyped headline of “Alzheimer’s Drug May Benefit Some Patients, New Data Shows.” We all… by Brian Moore, CDD Webpage: https://ift.tt/lhaKmbQ Bengaluru: December 06, 2022 at 01:33AM |
Zastra's JournalArchives
April 2023
Categories |